A recent functional MRI study investigated the patterns of brain activation associated with PPI in schizophrenic patients, and assessed whether the type of antipsychotic medication administered ...

Bajaj Health has also extended the offer for Pimavanserin to several leading pharma companies to ensure availability in ...

Antipsychotic drugs introduced over the past 15 years, often termed second-generation or atypical agents, were selected on the basis of a structural or pharmacological similarity to clozapine ...

Nine newer antipsychotics, called atypical antipsychotics, are used as "augmentation therapy," or add-ons to treat depression that hasn't responded to antidepressants or other treatments.

Management of adverse events is a major concern of clinicians who use antipsychotic drugs. The incidence of motor side effects is dose dependent. Atypical antipsychotic drugs are less likely to ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...

Bajaj Healthcare said that it has received approval from the Drug Controller General of India (DCGI) to manufacture both the API and drug formulation of Pimavanserin.

Bajaj Healthcare has received an approval from the Drug Controller General of India (DCGI) to manufacture both the API and Drug Formulation of Pimavanserin, a 34 mg capsule.

(An active ingredient is what makes a medication work.) It belongs to a group of drugs called atypical antipsychotics. Abilify is a brand-name medication that’s also available as the generic ...

Bajaj Healthcare receives DCGI approval to manufacture Pimavanserin, a generic medication for treating hallucinations and delusions associated with Parkinson's disease.